Krzysztof Chojnowski

Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia

Wojciech Jurczak, Krzysztof Chojnowski, Katarzyna Krawczyk et al. · British Journal of Haematology · 2018 · 217 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy

Tomasz Bednarczuk, Yuji Hiromatsu, Naoko Seki et al. · Human Immunology · 2004 · 53 citations

Medicine, Genetics, Ophthalmology +13

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma

Tadeusz Robak, Piotr Smolewski, Barbara Cebula‐Obrzut et al. · Cancer · 2006 · 50 citations

Medicine, Oncology, Pharmacotherapy +16

Heterogeneous Nuclear Ribonucleoprotein (HnRNP) K Genome-wide Binding Survey Reveals Its Role in Regulating 3′-End RNA Processing and Transcription Termination at the Early Growth Response 1 (EGR1) Gene through XRN2 Exonuclease*

Karol Bomsztyk, Krzysztof Goryca, Krzysztof Chojnowski et al. · Journal of Biological Chemistry · 2013 · 36 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

Assessment of Coagulation Disorders in Patients with Acute Leukemia Before and After Cytostatic Treatment

Krzysztof Chojnowski, Ewa Wawfuyniak, Jacek Treilinski et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1999 · 36 citations

Medicine, Hematology, Oncology +15